Literature DB >> 26390704

Expression and prognostic significance of microRNA-451 in human epithelial ovarian cancer.

S Ling, M Ruiqin, Z Guohong, W Ying.   

Abstract

OBJECTIVE: MicroRNA-451 has been proved to be downregulated in many human malignancies and correlated with tumor progression. However, its expression and clinical significance in epithelial ovarian cancer (EOC) is still unclear. The aim of this study was to explore the effects of miR-451 in EOC tumorigenesis and development.
MATERIALS AND METHODS: The expression levels of miR-451 were quantified by qRT-PCR in 115 EOC and 34 normal ovarian tissues, and correlated with clinicopathological factors and prognosis. MTT, flow cytometric assay, and transwell invasion assay were used to test the proliferation, apoptosis, and invasion of SKOV-3 EOC cells transfected with miR-451 mimics or negative control (NC) RNA-oligonucleotides.
RESULTS: MiR-451 expression was significantly downregulated in EOC compared with normal ovarian tissues. Low level of miR-451 was associated with advanced FIGO stage (p = 0.005), higher serum CA125 expression level (p = 0.005), and lymph node metastasis (p = 0.002). Multivariate Cox regression analysis identified decreased miR-451 expression as an independent factor predicting poor prognosis for EOC patients. In addition, transfection of miR-451 mimics in SKOV-3 was able to reduce cell proliferation, promote cell apoptosis, and inhibit cell invasion.
CONCLUSIONS: miR-451 may act not only as a novel diagnostic and prognostic marker, but also as a potential target for molecular therapy of EOC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26390704

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  7 in total

1.  Aberration of miRNAs Expression in Leukocytes from Sporadic Amyotrophic Lateral Sclerosis.

Authors:  YongPing Chen; QianQian Wei; XuePing Chen; ChunYu Li; Bei Cao; RuWei Ou; Shinji Hadano; Hui-Fang Shang
Journal:  Front Mol Neurosci       Date:  2016-08-17       Impact factor: 5.639

Review 2.  miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma.

Authors:  Emanuela Minna; Paola Romeo; Matteo Dugo; Loris De Cecco; Katia Todoerti; Silvana Pilotti; Federica Perrone; Ettore Seregni; Luca Agnelli; Antonino Neri; Angela Greco; Maria Grazia Borrello
Journal:  Oncotarget       Date:  2016-03-15

3.  Tumor suppressor activity of miR-451: Identification of CARF as a new target.

Authors:  Ling Li; Ran Gao; Yue Yu; Zeenia Kaul; Jia Wang; Rajkumar S Kalra; Zhenya Zhang; Sunil C Kaul; Renu Wadhwa
Journal:  Sci Rep       Date:  2018-01-10       Impact factor: 4.379

4.  MicroRNA-217 acts as a tumor suppressor and correlates with the chemoresistance of cervical carcinoma to cisplatin.

Authors:  Zhaojun Yin; Weiru Ren
Journal:  Onco Targets Ther       Date:  2019-01-23       Impact factor: 4.345

5.  Extracellular Vesicles from Uterine Aspirates Represent a Promising Source for Screening Markers of Gynecologic Cancers.

Authors:  Gleb O Skryabin; Andrey V Komelkov; Kirill I Zhordania; Dmitry V Bagrov; Svetlana V Vinokurova; Sergey A Galetsky; Nadezhda V Elkina; Darya A Denisova; Adel D Enikeev; Elena M Tchevkina
Journal:  Cells       Date:  2022-03-22       Impact factor: 6.600

6.  Combination microRNA-based cellular reprogramming with paclitaxel enhances therapeutic efficacy in a relapsed and multidrug-resistant model of epithelial ovarian cancer.

Authors:  Srujan K Gandham; Mounika Rao; Aayushi Shah; Malav S Trivedi; Mansoor M Amiji
Journal:  Mol Ther Oncolytics       Date:  2022-03-15       Impact factor: 7.200

Review 7.  miR-451: A Novel Biomarker and Potential Therapeutic Target for Cancer.

Authors:  Hua Bai; Suhui Wu
Journal:  Onco Targets Ther       Date:  2019-12-16       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.